In: Current Treatment Options in Neurology, 2015, vol. 17, no. 5, p. 1-14
|
In: Herz Kardiovaskuläre Erkrankungen, 2005, vol. 30, no. 3, p. 189-196
|
In: Nephrology Dialysis Transplantation, 1986, vol. 1, no. 3, p. 164-169
|
In: Archives of Cardiovascular Diseases, 2012, vol. 105, no. 11, p. 587–592
BackgroundThe salt linked to the clopidogrel molecule in generic preparations is suspected to affect its clinical efficacy. There is a lack of information about inhibition of platelet reactivity by generic preparations.AimsTo compare the effect of original clopidogrel (clopidogrel bisulphate [Plavix®]), generic clopidogrel preparations (clopidogrel hydrochloride...
|